Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-16-082050)

Filing Details

Accession Number:: 0001140361-16-082050
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-10-05 18:21:25
Reporting Period:: 2016-10-03

Filing Date:: 2016-10-05
Accepted Time:: 2016-10-05 18:21:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1527599	Mirna Therapeutics Inc.	MIRN	Pharmaceutical Preparations (2834)	261824804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1652055	Jon Irvin	C/O Mirna Therapeutics, Inc. 3711 South Mopac Expressway, Ste 100 Austin TX 78746	Vice President, Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-10-03	250	$1.93	8,485	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 29,2016.